• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News
    • Global health

    MSF bends donation policy for pneumonia vaccine

    MSF is accepting a limited supply of pneumonia vaccines from big pharma companies for the next three years, which could potentially dilute its campaign for lower vaccine prices. An official from the group's Access Campaign, however, doesn't believe it will.

    By Jenny Lei Ravelo // 22 January 2015

    After years of refusing vaccine handouts from big pharmaceutical companies, international medical humanitarian group Médecins Sans Frontières is bending its policy to accept donations of the pneumococcal conjugate vaccine.

    The announcement came at the same time the medical group launched a report that aimed to give a picture of the difficulties countries face in securing vaccines recommended by World Health Organization for routine immunizations without support from Gavi, the Vaccine Alliance. The public-private partnership is able to secure lower than market prices for 10 vaccines in the list, but this is only made available to Gavi-supported countries, as per agreement with pharma companies.

    Countries that have reached or are approaching a per capita gross national income of $1,570 will have to pay the full cost of each vaccine, and many of them are expecting to see a large increase in funding needed to finance their immunization campaigns as Gavi starts to phase out support. Indonesia, for instance, which is now being touted an emerging donor, would need to spend an estimated $32.31 million by 2018 to continue full immunization coverage, a 1,547 percent increase from the $2 million it spent in vaccine co-financing in 2012.

    This article is free to read - just register or sign in

    Access news, newsletters, events and more.

    Join usSign in
    • Global Health
    • Worldwide
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Jenny Lei Ravelo

      Jenny Lei Ravelo@JennyLeiRavelo

      Jenny Lei Ravelo is a Devex Senior Reporter based in Manila. She covers global health, with a particular focus on the World Health Organization, and other development and humanitarian aid trends in Asia Pacific. Prior to Devex, she wrote for ABS-CBN, one of the largest broadcasting networks in the Philippines, and was a copy editor for various international scientific journals. She received her journalism degree from the University of Santo Tomas.

    Search for articles

    Related Stories

    MalariaPrice of first malaria vaccine to be slashed by more than half

    Price of first malaria vaccine to be slashed by more than half

    Global healthHow Gavi is reaching ‘zero-dose’ children in conflict areas

    How Gavi is reaching ‘zero-dose’ children in conflict areas

    Global HealthRobert F. Kennedy Jr. says the US is cutting funding for Gavi

    Robert F. Kennedy Jr. says the US is cutting funding for Gavi

    Escape the Neglect: Produced in PartnershipWhy drug donation programs are a lifeline for NTD elimination efforts

    Why drug donation programs are a lifeline for NTD elimination efforts

    Most Read

    • 1
      The power of diagnostics to improve mental health
    • 2
      Lasting nutrition and food security needs new funding — and new systems
    • 3
      Opinion: Urgent action is needed to close the mobile gender gap
    • 4
      Supporting community-driven solutions to address breast cancer
    • 5
      The UN's changing of the guard
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement